Resource Center: DEA
Results 1 - 10 of 14
Search Results
Description:
This is the full text of Title 21, Chapter 13 of the US Code, which deals with drug abuse prevention and control.
Source:
Drug Enforcement Administration (DEA) 4.333335
Your rating: None Average: 4.3 (3 votes)
Tags:
Description:
This handout discusses how a prescribing physician may prepare for a visit from the DEA. Such visits are required by law for physicians prescribing buprenorphine, and involve things such as prescription and dispensing records, and adherence to prescribing limits on number of patients.
Source:
PCSS 0
Your rating: None
Tags:
Description:
This is a list of each state's prescription monitoring program contact information.
Source:
National Association of State Controlled Substances Authorities (NASCSA) 4.333335
Your rating: None Average: 4.3 (3 votes)
Tags:
Medical Recordkeeping
Description:
A description of what should be included in a buprenorphine patient's medical record. Many portions of the medical record contain general information that is not specific to patients with substance use disorders or opioid dependence.
0
Your rating: None
Tags:
Description:
This survey of 375 physicians found that confidence addressing drug problems was positively associated with having a buprenorphine waiver.
Source:
Journal of General Internal Medicine, 2007 4.5
Your rating: None Average: 4.5 (4 votes)
Description:
This 2006 document explains the Drug Enforcement Agency's (DEA) role in regulation of controlled substances and the physician's legal responsibility to prescribe controlled substances for legitimate medical purposes.
Source:
Drug Enforcement Agency (DEA) 4.333335
Your rating: None Average: 4.3 (3 votes)
Tags:
Description:
These FAQs address common questions regarding prescription drug monitoring programs.
Source:
Drug Enforcement Agency (DEA) 4
Your rating: None Average: 4 (4 votes)
Description:
Manual written by the DEA to assist physicians in understanding and complying with the Federal Controlled Substances Act. Topics covered include recordkeeping requirements, rules regarding prescription, and security requirements.
Source:
US Drug Enforcement Administration (DEA) 4.666665
Your rating: None Average: 4.7 (3 votes)
Tags:
Description:
This is the NASPER website which includes various information on the $60 million dollar 2005 grant to help states start or improve state-run prescription monitoring programs (PMPs).
Source:
American Society of Interventional Pain Physicians 4
Your rating: None Average: 4 (3 votes)
Tags:
Description:
This form is for physicians to notify the DEA (through the Substance Abuse and Mental Health Services Administration) of their intent to use Schedule III, IV, or V drugs for treatment of opioid dependent patients.
Source:
The National Alliance of Advocates for Buprenorphine Treatment (NAABT) 4.333335
Your rating: None Average: 4.3 (3 votes)
Tags:
- Home
- Training/CME
- Resources
- How-To Guides
- All How-To Guides
- Get Started Prescribing Buprenorphine
- Assess and Treat Patients with Comorbid Health Issues
- Conduct Buprenorphine Induction
- Establish and Manage a Buprenorphine Practice
- Manage Challenging Patients
- Comply with Rules, Regulations, and Recordkeeping
- Understand Insurance and Billing Issues
- Screen for Substance Abuse
- Refer Patients to an Addiction Specialist
- Review: What is Buprenorphine?
- Your Bup Site!
Current search
[×]
Tags
: DEARefine your results
Click a term to refine your current search.
Topics
- Rules, regulations and recordkeeping (10)
- Getting a waiver/setting up your practice (5)
- General information - buprenorphine (2)
- Physician and staff training (2)
- Special populations (1)
- Managing challenging patients (1)
- Logistics of buprenorphine treatment (1)
- Insurance and billing issues (1)
- Patient education materials (1)
Commonly Used Forms
Patient Handouts
- FAQ (1)
Physician stage in practice
- Setting up a practice (9)
- Becoming waivered (7)
- Experienced prescriber (7)
- Just became waivered (7)
- Need to refer (1)
